EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): C$0.20

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is C$0.21. In 2025 the company made an earnings per share (EPS) of C$0.24 an increase over its 2024 EPS that were of C$0.19.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	C$0.20	-13.74%
2025	C$0.24	24.14%
2024	C$0.19	42.43%
2023	C$0.13	8.77%
2022	C$0.12	-20.62%
2021	C$0.16	-26.59%
2020	C$0.21	27.24%
2019	C$0.17	28.41%
2018	C$0.13	20.04%
2017	C$0.11	31.21%
2016	C$0.08233	11.46%
2015	C$0.07387	36.27%
2014	C$0.05421	19.77%
2013	C$0.04526	18.05%
2012	C$0.03834	23.9%
2011	C$0.03094	26.9%
2010	C$0.02438	12.37%
2009	C$0.02170	56.6%
2008	C$0.01386	9.18%
2007	C$0.01269	114.48%
2006	C$0.005918	64.83%
2005	C$0.003590	35.55%
2004	C$0.002649	29.73%
2003	C$0.002042	19.86%
2002	C$0.001703	-2.71%
2001	C$0.001751	1.02%
2000	C$0.001733

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions